Lisa Salvatore

22PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer geneticsPublic health nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 04, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto

|Apr 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer.

Filippo Pietrantonio, Lisa Salvatore, Taito Esaki

|Jan 08, 2025
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF -mutated metastatic colorectal cancer treated with targeted therapy.

Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti

|Nov 27, 2024
A Retrospective Analysis of Real-Life Management of Colorectal Cancer Lung-Limited Metastases Treated with Surgery: Outcomes and Prognostic Factors.

Ina Valeria Zurlo, Maria Alessandra Calegari, Maria Teresa Congedo

Pageof 4